Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03401918 · ClinicalTrials.gov registry record · Phase 2
Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT03401918: Completed Phase 2 study, sponsored by Stanford University.
NCT03401918 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03401918, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if patients with recurrent pregnancy loss or unexplained infertility have an altered uterine gene expression or uterine microbiome (micro-organism composition) during the window of embryo implantation. Furthermore we would like to assess for women with an abnormal uterine gene expression whether vaginal progesterone medication improves or alters gene expression and for women with an abnormal microbiome whether antibiotic treatment followed by probiotic treatment normalizes the microbiome.
Interventions
- DIAGNOSTIC_TEST Uterine ERA and microbiome testing
- DRUG Oral antibiotics and vaginal probiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2021-07-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03401918
The ClinicalTrials.gov registry entry for NCT03401918 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Uterine ERA and microbiome testing is the first listed.
NCT03401918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03401918 about?
NCT03401918 is a clinical study titled "Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility". The purpose of this study is to determine if patients with recurrent pregnancy loss or unexplained infertility have an altered uterine gene expression or uterine microbiome (micro-organism composition) during the window of embryo implantation. Furthermore we would like to assess for women with an ab...
What is the current status of trial NCT03401918?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2017-08-01. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03401918?
The interventions under investigation include: Uterine ERA and microbiome testing (DIAGNOSTIC_TEST), Oral antibiotics and vaginal probiotics (DRUG).
Who is sponsoring clinical trial NCT03401918?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.